Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Illumina, Abbott, GlaxoSmithKline, J&J, Pfizer, Roche, sanofi-aventis, Wyeth, Columbia University, U.S. Food and Drug Administration genomics news

A group of pharmaceutical companies, academic institutions and FDA launched the non-profit International Serious Adverse Events Consortium (SAEC) to identify genetic markers

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE